Please use this identifier to cite or link to this item:
https://doi.org/10.1007/s10529-009-0007-4
DC Field | Value | |
---|---|---|
dc.title | Enhancement of bone formation by genetically-engineered bone marrow stromal cells expressing BMP-2, VEGF and angiopoietin-1 | |
dc.contributor.author | Hou, H. | |
dc.contributor.author | Zhang, X. | |
dc.contributor.author | Tang, T. | |
dc.contributor.author | Dai, K. | |
dc.contributor.author | Ge, R. | |
dc.date.accessioned | 2014-10-27T08:27:26Z | |
dc.date.available | 2014-10-27T08:27:26Z | |
dc.date.issued | 2009-07 | |
dc.identifier.citation | Hou, H., Zhang, X., Tang, T., Dai, K., Ge, R. (2009-07). Enhancement of bone formation by genetically-engineered bone marrow stromal cells expressing BMP-2, VEGF and angiopoietin-1. Biotechnology Letters 31 (8) : 1183-1189. ScholarBank@NUS Repository. https://doi.org/10.1007/s10529-009-0007-4 | |
dc.identifier.issn | 01415492 | |
dc.identifier.uri | http://scholarbank.nus.edu.sg/handle/10635/100581 | |
dc.description.abstract | To explore the potential of combined delivery of osteogenic and angiogenic factors to bone marrow stromal cells (BMSCs) for repair of critical-size bone defects, we followed the formation of bone and vessels in tissue-engineered constructs in nude mice and rabbit bone defects upon introducing different combinations of BMP-2, vascular endothelial growth factor (VEGF) and angiopoietin-1 (Ang-1) to BMSCs with adenoviral vectors. Better osteogenesis and angiogenesis were found in co-delivery group of BMP-2, VEGF and angiopoietin-1 than any other combination of these factors in both animal models, indicating combined gene delivery of angiopoietin-1 and VEGF165 into a tissue-engineered construct produces an additive effect on BMP-2-induced osteogenesis. © Springer Science+Business Media B.V. 2009. | |
dc.description.uri | http://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1007/s10529-009-0007-4 | |
dc.source | Scopus | |
dc.subject | Angiopoietin-1 | |
dc.subject | Bone morphogenic protein 2 | |
dc.subject | Bone tissue engineering | |
dc.subject | Critical-size bone defect | |
dc.subject | Vascular endothelial growth factor | |
dc.type | Article | |
dc.contributor.department | BIOLOGICAL SCIENCES | |
dc.description.doi | 10.1007/s10529-009-0007-4 | |
dc.description.sourcetitle | Biotechnology Letters | |
dc.description.volume | 31 | |
dc.description.issue | 8 | |
dc.description.page | 1183-1189 | |
dc.description.coden | BILED | |
dc.identifier.isiut | 000268002100009 | |
Appears in Collections: | Staff Publications |
Show simple item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.